Financials

  • Market Capitalization 101.45 M
  • Employee 5
  • Founded 2005
  • CEO N/A
  • Website www.neonc.com
  • Headquarter Delaware, United States
  • FIGI BBG01KPDB522
  • Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-2.58
ratio cours/chiffre d'affaires
4 011.7

Related tickers

#NomPrix24h %7 jours %1M %1 an %Cap Boursière7 Derniers Jours
3930
ONCY
Oncolytics Biotech Inc. - Common Stock
0.94 USD+1.08%+11.90%+14.63%-21.67%112.19 M USD
3942
BDTX
Black Diamond Therapeutics, Inc. - Common Stock
1.93 USD+1.58%-11.47%+7.22%-34.58%110.59 M USD
3968
KLRS
Kalaris Therapeutics, Inc. - Common Stock
4.38 USD-0.90%-4.99%-3.52%-57.18%104.21 M USD
3976
ANIX
Anixa Biosciences, Inc. - Common Stock
3.18 USD+3.92%+7.43%+23.74%-1.24%108.19 M USD